Diagnosis over the holidays

It may not be clear from my story but it was around the holidays in 1993 that I was having the worst of my symptoms and they prepared to send me to London for tests. Night sweats, back pain, lack of feeling in my feet while walking in the snow, etc.



I clearly remember going to a dinner party of an Embassy official on Boxing Day, December 26th. Generally I was cold and I wore a thick sweater I had bought in Nepal. All of a sudden I was extremely warm and a bit dizzy from then on.



Having lymphoma, and later finding out it was cancer, during the holidays was especially hard. Winter already makes people sad. Having a life threatening illness makes it 10 times (or more) worse.



But just as Spring arrived, I started treatment and with late Summer, remission. The thaw brought new hope and optimism that I hope to bring to you with this blog and website. While the circumstances of your visit here may be sad, I want to assure you the hope is real.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap